Dow Today: Walt Disney (DIS) Leads The Day Higher, Johnson & Johnson (JNJ) Lags

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

The Dow Jones Industrial Average ( ^DJI) is trading down 34.0 points (-0.2%) at 14,531 as of Monday, Apr 8, 2013, 9:35 a.m. ET. During this time, 29.1 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 603.7 million. The NYSE advances/declines ratio sits at 1,435 issues advancing vs. 1,568 declining with 108 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Walt Disney (NYSE: DIS), which is sporting a 52-cent gain (+0.9%) bringing the stock to $58.22. Volume for Walt Disney currently sits at 938,928 shares traded vs. an average daily trading volume of 8.3 million shares.

Walt Disney has a market cap of $103.98 billion and is part of the services sector and media industry. Shares are up 15.9% year to date as of Friday's close. The stock's dividend yield sits at 1.3%.

The Walt Disney Company operates as an entertainment company worldwide. Its Media Networks segment engages in broadcast television network, television production and distribution, television stations, broadcast radio networks and stations, and publishing and digital operations. The company has a P/E ratio of 18.6, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Walt Disney as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, largely solid financial position with reasonable debt levels by most measures, notable return on equity and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

Holding back the Dow today is Johnson & Johnson (NYSE: JNJ), which is lagging the broader Dow index with a $1.18 decline (-1.4%) bringing the stock to $80.86. This single loss is lowering the Dow Jones Industrial Average by 8.93 points or roughly accounting for 26.3% of the Dow's overall loss. Volume for Johnson & Johnson currently sits at 1.4 million shares traded vs. an average daily trading volume of 9.6 million shares.

Johnson & Johnson has a market cap of $230.5 billion and is part of the health care sector and drugs industry. Shares are up 17% year to date as of Friday's close. The stock's dividend yield sits at 3%.

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The company has a P/E ratio of 21.3, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

Market Selloff Survival Strategies: Cramer's 'Mad Money' Recap (Thurs 9/21/17)

Royal Caribbean Cruise Set to Sail Through Caribbean Hurricane Disasters?

Microsoft's New Xbox One X Shows It's Done Trying to Please Everyone

'The Handmaid's Tale' Emmy Win Is Really Big for Netflix

Stocks Dad Would Have Loved, And Why He Was Right